{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:45:29Z","timestamp":1791125129096,"version":"4.1.0"},"reference-count":192,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,13]]},"DOI":"10.1097\/qad.0b013e3283437f9a","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T04:03:17Z","timestamp":1292299397000},"page":"561-575","source":"Crossref","is-referenced-by-count":211,"title":["HIV-1 infection and cognitive impairment in the cART era: a review"],"prefix":"10.1097","volume":"25","author":[{"given":"Judith","family":"Schouten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cinque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Gisslen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Portegies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.410190602","article-title":"The AIDS dementia complex: I. Clinical features","volume":"19","author":"Navia","year":"1986","journal-title":"Ann Neurol"},{"key":"R2-3-20210130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ana.410190603","article-title":"The AIDS dementia complex: II. Neuropathology","volume":"19","author":"Navia","year":"1986","journal-title":"Ann Neurol"},{"key":"R3-3-20210130","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"R4-3-20210130","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","article-title":"Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.","volume":"24","author":"Simioni","year":"2010","journal-title":"AIDS"},{"key":"R5-3-20210130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/13550280490521078","article-title":"Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected\/acquired immunodeficiency syndrome (HIV\/AIDS) patients across pre and posthighly active antiretroviral therapy eras: a combined study of two cohorts","volume":"10","author":"Cysique","year":"2004","journal-title":"J Neurovirol"},{"key":"R6-3-20210130","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/01.WNL.0000038347.48137.67","article-title":"Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity","volume":"59","author":"Hinkin","year":"2002","journal-title":"Neurology"},{"key":"R7-3-20210130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1017\/S1355617706060401","article-title":"The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis","volume":"12","author":"Cysique","year":"2006","journal-title":"J Int Neuropsychol Soc"},{"key":"R8-3-20210130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11065-009-9102-5","article-title":"Cognitive neuropsychology of HIV-associated neurocognitive disorders","volume":"19","author":"Woods","year":"2009","journal-title":"Neuropsychol Rev"},{"key":"R9-3-20210130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1468-1293.2008.00679.x","article-title":"Neurocognitive screening tools in HIV\/AIDS: comparative performance among patients exposed to antiretroviral therapy","volume":"10","author":"Skinner","year":"2009","journal-title":"HIV Med"},{"key":"R10-3-20210130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00042560-199503010-00008","article-title":"HIV Dementia Scale: a rapid screening test","volume":"8","author":"Power","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R11-3-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2006.03.023","article-title":"The HIV Dementia Scale: predictive power in mild dementia and HAART","volume":"260","author":"Bottiggi","year":"2007","journal-title":"J Neurol Sci"},{"key":"R12-3-20210130","first-page":"1367","article-title":"The International HIV Dementia Scale: a new rapid screening test for HIV dementia","volume":"19","author":"Sacktor","year":"2005","journal-title":"AIDS"},{"key":"R14-3-20210130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archneur.55.2.161","article-title":"Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group","volume":"55","author":"Stout","year":"1998","journal-title":"Arch Neurol"},{"key":"R15-3-20210130","first-page":"543","article-title":"Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients","volume":"23","author":"Patel","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"R16-3-20210130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neuroimage.2006.08.030","article-title":"3D pattern of brain atrophy in HIV\/AIDS visualized using tensor-based morphometry","volume":"34","author":"Chiang","year":"2007","journal-title":"Neuroimage"},{"key":"R17-3-20210130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1468-1331.2006.01173.x","article-title":"The nervous system in early HIV infection: a prospective study through 7 years","volume":"13","author":"Samuelsson","year":"2006","journal-title":"Eur J Neurol"},{"key":"R18-3-20210130","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1212\/WNL.42.11.2125","article-title":"Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis","volume":"42","author":"Dal Pan","year":"1992","journal-title":"Neurology"},{"key":"R19-3-20210130","first-page":"252","article-title":"Incidental white matter hyperintensities on magnetic resonance imaging in HIV-1 infection. Multicenter AIDS Cohort Study","volume":"3","author":"McArthur","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R20-3-20210130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0149-7634(02)00006-4","article-title":"Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1","volume":"26","author":"Paul","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"R21-3-20210130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archneur.61.3.369","article-title":"Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss","volume":"61","author":"Archibald","year":"2004","journal-title":"Arch Neurol"},{"key":"R23-3-20210130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.52.1.100","article-title":"Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex","volume":"52","author":"Chang","year":"1999","journal-title":"Neurology"},{"key":"R24-3-20210130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1148\/radiol.09081867","article-title":"Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia","volume":"254","author":"Mohamed","year":"2010","journal-title":"Radiology"},{"key":"R25-3-20210130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jmri.20272","article-title":"A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia","volume":"21","author":"Sacktor","year":"2005","journal-title":"J Magn Reson Imaging"},{"key":"R26-3-20210130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2004.08.036","article-title":"Neuroimaging in human immunodeficiency virus infection","volume":"157","author":"Tucker","year":"2004","journal-title":"J Neuroimmunol"},{"key":"R27-3-20210130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1212\/WNL.56.1.112","article-title":"Clinical and spectroscopic improvement in HIV-associated cognitive impairment","volume":"56","author":"Stankoff","year":"2001","journal-title":"Neurology"},{"key":"R28-3-20210130","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1212\/WNL.53.4.782","article-title":"Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia","volume":"53","author":"Chang","year":"1999","journal-title":"Neurology"},{"key":"R29-3-20210130","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/1522-2586(200012)12:6<859::AID-JMRI8>3.0.CO;2-T","article-title":"Changes in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: a coregistered (1)H MRS and SPECT study","volume":"12","author":"Ernst","year":"2000","journal-title":"J Magn Reson Imaging"},{"key":"R30-3-20210130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1017\/S1355617708080910","article-title":"Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV","volume":"14","author":"Paul","year":"2008","journal-title":"J Int Neuropsychol Soc"},{"key":"R31-3-20210130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0925-4927(00)00082-2","article-title":"White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study","volume":"106","author":"Pomara","year":"2001","journal-title":"Psychiatry Res"},{"key":"R32-3-20210130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/13550280590953799","article-title":"Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus","volume":"11","author":"Ragin","year":"2005","journal-title":"J Neurovirol"},{"key":"R33-3-20210130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/13550280902769756","article-title":"White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals","volume":"15","author":"Gongvatana","year":"2009","journal-title":"J Neurovirol"},{"key":"R34-3-20210130","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.neuroimage.2009.04.030","article-title":"White matter abnormalities revealed by diffusion tensor imaging in nondemented and demented HIV+ patients","volume":"47","author":"Chen","year":"2009","journal-title":"Neuroimage"},{"key":"R35-3-20210130","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1212\/WNL.50.6.1821","article-title":"Increased cerebral blood volume in HIV-positive patients detected by functional MRI","volume":"50","author":"Tracey","year":"1998","journal-title":"Neurology"},{"key":"R36-3-20210130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.21594","article-title":"Declined neural efficiency in cognitively stable human immunodeficiency virus patients","volume":"65","author":"Ernst","year":"2009","journal-title":"Ann Neurol"},{"key":"R37-3-20210130","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S1053-8119(03)00232-5","article-title":"Increased glial metabolites predict increased working memory network activation in HIV brain injury","volume":"19","author":"Ernst","year":"2003","journal-title":"Neuroimage"},{"key":"R38-3-20210130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1212\/WNL.54.2.389","article-title":"Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex","volume":"54","author":"Chang","year":"2000","journal-title":"Neurology"},{"key":"R39-3-20210130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/WNL.0b013e3181b59a97","article-title":"Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain","volume":"73","author":"Ances","year":"2009","journal-title":"Neurology"},{"key":"R40-3-20210130","first-page":"895","article-title":"Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine","volume":"18","author":"Dousset","year":"1997","journal-title":"AJNR Am J Neuroradiol"},{"key":"R41-3-20210130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3174\/ajnr.A0740","article-title":"Whole brain and localized magnetization transfer measurements are associated with cognitive impairment in patients infected with human immunodeficiency virus","volume":"29","author":"Wu","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"R42-3-20210130","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archneur.1995.00540360048015","article-title":"A comparison of cerebral SPECT abnormalities in HIV-positive homosexual men with and without cognitive impairment","volume":"52","author":"Sacktor","year":"1995","journal-title":"Arch Neurol"},{"key":"R43-3-20210130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/00365549950163761","article-title":"SPECT with 99mTc-HMPAO in subjects with HIV infection: cognitive dysfunction correlates with high uptake","volume":"31","author":"Christensson","year":"1999","journal-title":"Scand J Infect Dis"},{"key":"R44-3-20210130","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.57.11.1601","article-title":"Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings","volume":"57","author":"von Giesen","year":"2000","journal-title":"Arch Neurol"},{"key":"R45-3-20210130","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1086\/375152","article-title":"Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy","volume":"187","author":"Ellis","year":"2003","journal-title":"J Infect Dis"},{"key":"R46-3-20210130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00002030-199804000-00007","article-title":"Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis","volume":"12","author":"Cinque","year":"1998","journal-title":"AIDS"},{"key":"R47-3-20210130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-6405-7-15","article-title":"Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection","volume":"7","author":"Hagberg","year":"2010","journal-title":"AIDS Res Ther"},{"key":"R48-3-20210130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0165-5728(99)00219-2","article-title":"Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine","volume":"102","author":"Enting","year":"2000","journal-title":"J Neuroimmunol"},{"key":"R49-3-20210130","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/00002030-199811000-00014","article-title":"Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication","volume":"12","author":"Cinque","year":"1998","journal-title":"AIDS"},{"key":"R50-3-20210130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ana.410440521","article-title":"Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia","volume":"44","author":"Kelder","year":"1998","journal-title":"Ann Neurol"},{"key":"R51-3-20210130","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00415-006-0481-8","article-title":"CSF neurofilament protein (NFL): a marker of active HIV-related neurodegeneration","volume":"254","author":"Abdulle","year":"2007","journal-title":"J Neurol"},{"key":"R52-3-20210130","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00002030-199906180-00008","article-title":"Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection","volume":"13","author":"Staprans","year":"1999","journal-title":"AIDS"},{"key":"R53-3-20210130","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.54.4.927","article-title":"Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources","volume":"54","author":"Ellis","year":"2000","journal-title":"Neurology"},{"key":"R54-3-20210130","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/088922201750102409","article-title":"Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid","volume":"17","author":"Cinque","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R55-3-20210130","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/00002030-200309050-00008","article-title":"Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration","volume":"17","author":"Eggers","year":"2003","journal-title":"AIDS"},{"key":"R56-3-20210130","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/01.wnl.0000277635.05973.55","article-title":"Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection","volume":"69","author":"Mellgren","year":"2007","journal-title":"Neurology"},{"key":"R57-3-20210130","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1212\/01.WNL.0000145763.68284.15","article-title":"Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia","volume":"63","author":"Sevigny","year":"2004","journal-title":"Neurology"},{"key":"R58-3-20210130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.qai.0000165799.59322.f5","article-title":"Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients","volume":"39","author":"Cysique","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R59-3-20210130","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1086\/508750","article-title":"Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure","volume":"194","author":"Spudich","year":"2006","journal-title":"J Infect Dis"},{"key":"R60-3-20210130","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/135965350601100707","article-title":"Cerebrospinal fluid viral loads reach less than 2 copies\/ml in HIV-1-infected patients with effective antiretroviral therapy","volume":"11","author":"Yilmaz","year":"2006","journal-title":"Antivir Ther"},{"key":"R61-3-20210130","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/QAD.0b013e328331e15b","article-title":"Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation","volume":"24","author":"Probasco","year":"2010","journal-title":"AIDS"},{"key":"R63-3-20210130","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/650538","article-title":"Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy","volume":"50","author":"Canestri","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R64-3-20210130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00126334-200012150-00007","article-title":"Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy","volume":"25","author":"Gisolf","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R65-3-20210130","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1086\/523648","article-title":"Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy","volume":"196","author":"Eden","year":"2007","journal-title":"J Infect Dis"},{"key":"R66-3-20210130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.jnen.0000202887.22082.63","article-title":"Microglia in the aging brain","volume":"65","author":"Conde","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"R67-3-20210130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.neuro.22.1.219","article-title":"Microglia as mediators of inflammatory and degenerative diseases","volume":"22","author":"Gonzalez-Scarano","year":"1999","journal-title":"Annu Rev Neurosci"},{"key":"R68-3-20210130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2377-9-63","article-title":"Amyloid and tau cerebrospinal fluid biomarkers in HIV infection","volume":"9","author":"Gisslen","year":"2009","journal-title":"BMC Neurol"},{"key":"R69-3-20210130","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1128\/JVI.01890-08","article-title":"Hepatitis C virus neuroinvasion: identification of infected cells","volume":"83","author":"Wilkinson","year":"2009","journal-title":"J Virol"},{"key":"R70-3-20210130","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1212\/WNL.0b013e3181f11bd8","article-title":"Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.","volume":"75","author":"Wright","year":"2010","journal-title":"Neurology"},{"key":"R71-3-20210130","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.0b013e3181d9ed09","article-title":"Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort","volume":"74","author":"Robertson","year":"2010","journal-title":"Neurology"},{"key":"R72-3-20210130","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ana.20076","article-title":"The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations","volume":"55","author":"Cinque","year":"2004","journal-title":"Ann Neurol"},{"key":"R73-3-20210130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2007.08.004","article-title":"CSF proteomic fingerprints for HIV-associated cognitive impairment","volume":"192","author":"Laspiur","year":"2007","journal-title":"J Neuroimmunol"},{"key":"R74-3-20210130","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1172\/JCI34138","article-title":"Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques","volume":"118","author":"Wikoff","year":"2008","journal-title":"J Clin Invest"},{"key":"R75-3-20210130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1750-3639.1991.tb00656.x","article-title":"Neuropathology of human immunodeficiency virus infection","volume":"1","author":"Budka","year":"1991","journal-title":"Brain Pathol"},{"key":"R76-3-20210130","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2559.2004.02004.x","article-title":"An update on the neuropathology of HIV in the HAART era","volume":"45","author":"Bell","year":"2004","journal-title":"Histopathology"},{"key":"R77-3-20210130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1750-3639.1998.tb00153.x","article-title":"Distribution of brain HIV load in AIDS","volume":"8","author":"Wiley","year":"1998","journal-title":"Brain Pathol"},{"key":"R78-3-20210130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1750-3639.1999.tb00219.x","article-title":"Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center","volume":"9","author":"Everall","year":"1999","journal-title":"Brain Pathol"},{"key":"R79-3-20210130","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/01.aids.0000218552.69834.00","article-title":"Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment","volume":"20","author":"Moore","year":"2006","journal-title":"AIDS"},{"key":"R80-3-20210130","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/01.WNL.0000034175.11956.79","article-title":"Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis","volume":"59","author":"Cherner","year":"2002","journal-title":"Neurology"},{"key":"R81-3-20210130","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ana.410390319","article-title":"Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome","volume":"39","author":"Johnson","year":"1996","journal-title":"Ann Neurol"},{"key":"R82-3-20210130","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-2006-956759","article-title":"Dementia and neurocognitive disorders due to HIV-1 infection","volume":"27","author":"Ances","year":"2007","journal-title":"Semin Neurol"},{"key":"R83-3-20210130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.410380404","article-title":"AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations","volume":"38","author":"Brew","year":"1995","journal-title":"Ann Neurol"},{"key":"R84-3-20210130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/13550280903131915","article-title":"Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy","volume":"15","author":"Everall","year":"2009","journal-title":"J Neurovirol"},{"key":"R85-3-20210130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/13550280701327038","article-title":"Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction","volume":"13","author":"Kumar","year":"2007","journal-title":"J Neurovirol"},{"key":"R86-3-20210130","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ana.410380510","article-title":"Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia","volume":"38","author":"Glass","year":"1995","journal-title":"Ann Neurol"},{"key":"R87-3-20210130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnen\/64.6.529","article-title":"Influence of HAART on HIV-related CNS disease and neuroinflammation","volume":"64","author":"Anthony","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"R88-3-20210130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/13550280600713932","article-title":"Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients","volume":"12","author":"Langford","year":"2006","journal-title":"J Neurovirol"},{"key":"R89-3-20210130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s004010000245","article-title":"Neuropathology and general autopsy findings in AIDS during the last 15 years","volume":"100","author":"Jellinger","year":"2000","journal-title":"Acta Neuropathol"},{"key":"R90-3-20210130","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1097\/00002030-200209270-00009","article-title":"Pathological findings in the central nervous system of AIDS patients on assumed antiretroviral therapeutic regimens: retrospective study of 1597 autopsies","volume":"16","author":"Vago","year":"2002","journal-title":"AIDS"},{"key":"R91-3-20210130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/jnen\/62.5.429","article-title":"The changing pattern of HIV neuropathology in the HAART era","volume":"62","author":"Gray","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"R92-3-20210130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00002030-200001070-00008","article-title":"Changes in pathological findings at autopsy in AIDS cases for the last 15 years","volume":"14","author":"Masliah","year":"2000","journal-title":"AIDS"},{"key":"R93-3-20210130","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.42.9.1736","article-title":"Early viral brain invasion in iatrogenic human immunodeficiency virus infection","volume":"42","author":"Davis","year":"1992","journal-title":"Neurology"},{"key":"R94-3-20210130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-125-4-199608150-00001","article-title":"Clinical and epidemiologic features of primary HIV infection","volume":"125","author":"Schacker","year":"1996","journal-title":"Ann Intern Med"},{"key":"R95-3-20210130","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1084\/jem.166.4.1138","article-title":"Modulation of CD4 antigen on macrophages and microglia in rat brain","volume":"166","author":"Perry","year":"1987","journal-title":"J Exp Med"},{"key":"R96-3-20210130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126334-199908010-00003","article-title":"Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection","volume":"21","author":"Gisslen","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R97-3-20210130","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1126\/science.3277272","article-title":"The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex","volume":"239","author":"Price","year":"1988","journal-title":"Science"},{"key":"R98-3-20210130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF03033823","article-title":"The role of monocytes and perivascular macrophages in HIV and SIV neuropathogenesis: information from nonhuman primate models","volume":"8","author":"Kim","year":"2005","journal-title":"Neurotox Res"},{"key":"R99-3-20210130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The neuropathogenesis of AIDS","volume":"5","author":"Gonzalez-Scarano","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R100-3-20210130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.21697","article-title":"Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia","volume":"66","author":"Churchill","year":"2009","journal-title":"Ann Neurol"},{"key":"R101-3-20210130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1570162033485122","article-title":"Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia","volume":"1","author":"Gorry","year":"2003","journal-title":"Curr HIV Res"},{"key":"R102-3-20210130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(02)00207-1","article-title":"The role of macrophage\/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis","volume":"202","author":"Minagar","year":"2002","journal-title":"J Neurol Sci"},{"key":"R103-3-20210130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410340307","article-title":"Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier","volume":"34","author":"Power","year":"1993","journal-title":"Ann Neurol"},{"key":"R104-3-20210130","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1212\/WNL.42.9.1707","article-title":"The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study","volume":"42","author":"McArthur","year":"1992","journal-title":"Neurology"},{"key":"R105-3-20210130","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/135502801753248123","article-title":"Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals: correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels","volume":"7","author":"Andersson","year":"2001","journal-title":"J Neurovirol"},{"key":"R106-3-20210130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11481-006-9011-9","article-title":"Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS","volume":"1","author":"Kaul","year":"2006","journal-title":"J Neuroimmune Pharmacol"},{"key":"R107-3-20210130","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1086\/518043","article-title":"Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex","volume":"195","author":"Gisslen","year":"2007","journal-title":"J Infect Dis"},{"key":"R108-3-20210130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","article-title":"Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients","volume":"19","author":"Green","year":"2005","journal-title":"AIDS"},{"key":"R109-3-20210130","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181c5b445","article-title":"CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease","volume":"73","author":"Clifford","year":"2009","journal-title":"Neurology"},{"issue":"Suppl 3","key":"R110-3-20210130","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1086\/533419","article-title":"Antiretroviral therapy and central nervous system HIV type 1 infection","volume":"197","author":"Price","year":"2008","journal-title":"J Infect Dis"},{"key":"R111-3-20210130","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/QAD.0b013e3283299129","article-title":"Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course","volume":"23","author":"Harrington","year":"2009","journal-title":"AIDS"},{"key":"R112-3-20210130","doi-asserted-by":"crossref","first-page":"e1000395","DOI":"10.1371\/journal.ppat.1000395","article-title":"Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia","volume":"5","author":"Schnell","year":"2009","journal-title":"PLoS Pathog"},{"key":"R113-3-20210130","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.0605513103","article-title":"The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia","volume":"103","author":"Dunfee","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R114-3-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13550280600915339","article-title":"Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection: The Hawaii Aging with HIV Cohort","volume":"12","author":"Valcour","year":"2006","journal-title":"J Neurovirol"},{"key":"R115-3-20210130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jneuroim.2004.08.029","article-title":"Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort","volume":"157","author":"Valcour","year":"2004","journal-title":"J Neuroimmunol"},{"key":"R116-3-20210130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2004.08.027","article-title":"CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults","volume":"157","author":"Singh","year":"2004","journal-title":"J Neuroimmunol"},{"key":"R117-3-20210130","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ana.21292","article-title":"Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif","volume":"63","author":"Mishra","year":"2008","journal-title":"Ann Neurol"},{"key":"R118-3-20210130","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/605284","article-title":"HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda","volume":"49","author":"Sacktor","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R119-3-20210130","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/QAD.0b013e3283389dcc","article-title":"HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children","volume":"24","author":"Boivin","year":"2010","journal-title":"AIDS"},{"key":"R120-3-20210130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410330403","article-title":"Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group","volume":"33","author":"Sidtis","year":"1993","journal-title":"Ann Neurol"},{"key":"R121-3-20210130","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/bmj.299.6703.819","article-title":"Declining incidence of AIDS dementia complex after introduction of zidovudine treatment","volume":"299","author":"Portegies","year":"1989","journal-title":"BMJ"},{"key":"R122-3-20210130","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/00002030-199910010-00011","article-title":"Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment","volume":"13","author":"Tozzi","year":"1999","journal-title":"AIDS"},{"key":"R123-3-20210130","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/01.wnl.0000210477.63851.d3","article-title":"Variable benefit in neuropsychological function in HIV-infected HAART-treated patients","volume":"66","author":"Cysique","year":"2006","journal-title":"Neurology"},{"key":"R124-3-20210130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/QAI.0b013e318042e1ee","article-title":"Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors","volume":"45","author":"Tozzi","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R125-3-20210130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00126334-200405010-00003","article-title":"Highly active antiretroviral therapy improves neurocognitive functioning","volume":"36","author":"Robertson","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R126-3-20210130","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1212\/01.WNL.0000058768.73358.1A","article-title":"Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy","volume":"60","author":"Marra","year":"2003","journal-title":"Neurology"},{"key":"R127-3-20210130","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e3280ef6acd","article-title":"HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients","volume":"21","author":"McCutchan","year":"2007","journal-title":"AIDS"},{"key":"R128-3-20210130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.0b013e3181ab2b3b","article-title":"Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy","volume":"73","author":"Cysique","year":"2009","journal-title":"Neurology"},{"key":"R129-3-20210130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.20198","article-title":"Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders","volume":"56","author":"Letendre","year":"2004","journal-title":"Ann Neurol"},{"key":"R130-3-20210130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch Neurol"},{"key":"R132-3-20210130","first-page":"45","article-title":"Neurologic complications of HIV disease and their treatment","volume":"18","author":"Letendre","year":"2010","journal-title":"Top HIV Med"},{"key":"R133-3-20210130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/QAI.0b013e3181af83d6","article-title":"Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders","volume":"52","author":"Tozzi","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R135-3-20210130","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","article-title":"Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance","volume":"23","author":"Marra","year":"2009","journal-title":"AIDS"},{"key":"R136-3-20210130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11065-009-9092-3","article-title":"Neuropsychological functioning and antiretroviral treatment in HIV\/AIDS: a review","volume":"19","author":"Cysique","year":"2009","journal-title":"Neuropsychol Rev"},{"key":"R137-3-20210130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/13550280591002342","article-title":"Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors","volume":"11","author":"Schweinsburg","year":"2005","journal-title":"J Neurovirol"},{"key":"R138-3-20210130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/135965350501000203","article-title":"The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function","volume":"10","author":"Piccinini","year":"2005","journal-title":"Antivir Ther"},{"key":"R139-3-20210130","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-1293.2006.00419.x","article-title":"Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study","volume":"7","author":"Rihs","year":"2006","journal-title":"HIV Med"},{"key":"R140-3-20210130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1310\/hct1006-343","article-title":"Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s)","volume":"10","author":"Clifford","year":"2009","journal-title":"HIV Clin Trials"},{"key":"R141-3-20210130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-6405-2-6","article-title":"Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection","volume":"2","author":"Gisslen","year":"2005","journal-title":"AIDS Res Ther"},{"key":"R143-3-20210130","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"R144-3-20210130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22053","article-title":"Human immunodeficiency virus-associated neurocognitive disorders: mind the gap","volume":"67","author":"McArthur","year":"2010","journal-title":"Ann Neurol"},{"key":"R145-3-20210130","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1076\/jcen.24.7.912.8391","article-title":"Reaction time performance in adults with HIV\/AIDS","volume":"24","author":"Hardy","year":"2002","journal-title":"J Clin Exp Neuropsychol"},{"key":"R146-3-20210130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/13803390701565225","article-title":"Variable patterns of neuropsychological performance in HIV-1 infection","volume":"30","author":"Dawes","year":"2008","journal-title":"J Clin Exp Neuropsychol"},{"key":"R147-3-20210130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/13803390601186684","article-title":"Elements of attention in HIV-infected adults: evaluation of an existing model","volume":"30","author":"Levine","year":"2008","journal-title":"J Clin Exp Neuropsychol"},{"key":"R148-3-20210130","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/13803390590949494","article-title":"Prospective memory in HIV-1 infection","volume":"28","author":"Carey","year":"2006","journal-title":"J Clin Exp Neuropsychol"},{"key":"R149-3-20210130","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/13803390500205684","article-title":"Timed Gait test: normative data for the assessment of the AIDS dementia complex","volume":"28","author":"Robertson","year":"2006","journal-title":"J Clin Exp Neuropsychol"},{"key":"R150-3-20210130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1017\/S1355617703910071","article-title":"Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments","volume":"9","author":"Gonzalez","year":"2003","journal-title":"J Int Neuropsychol Soc"},{"key":"R151-3-20210130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/arclin\/acp010","article-title":"Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex","volume":"24","author":"Maruff","year":"2009","journal-title":"Arch Clin Neuropsychol"},{"key":"R152-3-20210130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0072-9752(07)85017-2","article-title":"Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex","volume":"85","author":"Cinque","year":"2007","journal-title":"Handb Clin Neurol"},{"key":"R153-3-20210130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11481-009-9154-6","article-title":"Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders","volume":"4","author":"Jayadev","year":"2009","journal-title":"J Neuroimmune Pharmacol"},{"key":"R154-3-20210130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13550280590952790","article-title":"Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort","volume":"11","author":"Tozzi","year":"2005","journal-title":"J Neurovirol"},{"key":"R155-3-20210130","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/01.aids.0000238404.16121.47","article-title":"Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection","volume":"20","author":"Parsons","year":"2006","journal-title":"AIDS"},{"key":"R156-3-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1300\/J069v27n02_02","article-title":"Neurocognition in individuals co-infected with HIV and hepatitis C","volume":"27","author":"Hinkin","year":"2008","journal-title":"J Addict Dis"},{"key":"R157-3-20210130","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/j.1532-5415.2009.02494.x","article-title":"Human immunodeficiency virus in an aging population, a complication of success","volume":"57","author":"Kirk","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"R158-3-20210130","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/01.WNL.0000134665.58343.8D","article-title":"Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort","volume":"63","author":"Valcour","year":"2004","journal-title":"Neurology"},{"key":"R159-3-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1355617704101021","article-title":"Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons","volume":"10","author":"Rippeth","year":"2004","journal-title":"J Int Neuropsychol Soc"},{"key":"R160-3-20210130","doi-asserted-by":"crossref","first-page":"e2516","DOI":"10.1371\/journal.pone.0002516","article-title":"Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients","volume":"3","author":"Ancuta","year":"2008","journal-title":"PLoS One"},{"key":"R161-3-20210130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.qai.0000243119.67529.f5","article-title":"Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort","volume":"43","author":"Valcour","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R162-3-20210130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13854040903482830","article-title":"Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age","volume":"24","author":"Foley","year":"2010","journal-title":"Clin Neuropsychol"},{"key":"R163-3-20210130","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.43.11.2245","article-title":"Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study","volume":"43","author":"McArthur","year":"1993","journal-title":"Neurology"},{"key":"R164-3-20210130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1037\/0894-4105.17.3.410","article-title":"Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis","volume":"17","author":"Carter","year":"2003","journal-title":"Neuropsychology"},{"key":"R165-3-20210130","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archneur.64.9.1264","article-title":"Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus-associated dementia","volume":"64","author":"Wachtman","year":"2007","journal-title":"Arch Neurol"},{"key":"R167-3-20210130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00004714-199208000-00009","article-title":"Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment","volume":"12","author":"Angrist","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"R168-3-20210130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1176\/jnp.13.2.248","article-title":"Methylphenidate improves HIV-1-associated cognitive slowing","volume":"13","author":"Hinkin","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R169-3-20210130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1212\/WNL.54.1.233","article-title":"Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study","volume":"54","author":"Sacktor","year":"2000","journal-title":"Neurology"},{"key":"R170-3-20210130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.50.3.645","article-title":"A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.","volume":"50","year":"1998","journal-title":"Neurology"},{"key":"R171-3-20210130","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1212\/WNL.0b013e3181c51a48","article-title":"Selegiline and oxidative stress in HIV-associated cognitive impairment","volume":"73","author":"Schifitto","year":"2009","journal-title":"Neurology"},{"key":"R172-3-20210130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1310\/hct0806-437","article-title":"Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090","volume":"8","author":"Evans","year":"2007","journal-title":"HIV Clin Trials"},{"key":"R173-3-20210130","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1523\/JNEUROSCI.23-27-09162.2003","article-title":"Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis","volume":"23","author":"Dou","year":"2003","journal-title":"J Neurosci"},{"key":"R174-3-20210130","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.neuroscience.2006.02.065","article-title":"Valproic acid induces caspase 3-mediated apoptosis in microglial cells","volume":"140","author":"Dragunow","year":"2006","journal-title":"Neuroscience"},{"key":"R175-3-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13550280500516278","article-title":"Modulation of human immunodeficiency virus infection by anticonvulsant drugs","volume":"12","author":"Robinson","year":"2006","journal-title":"J Neurovirol"},{"key":"R176-3-20210130","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/01.wnl.0000204294.28189.03","article-title":"Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report","volume":"66","author":"Schifitto","year":"2006","journal-title":"Neurology"},{"key":"R177-3-20210130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2377-6-42","article-title":"Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study","volume":"6","author":"Cysique","year":"2006","journal-title":"BMC Neurol"},{"key":"R178-3-20210130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1212\/WNL.53.2.391","article-title":"Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium","volume":"53","author":"Schifitto","year":"1999","journal-title":"Neurology"},{"key":"R179-3-20210130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1212\/WNL.51.1.221","article-title":"A phase I\/II trial of nimodipine for HIV-related neurologic complications","volume":"51","author":"Navia","year":"1998","journal-title":"Neurology"},{"key":"R180-3-20210130","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1523\/JNEUROSCI.1933-04.2004","article-title":"Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis","volume":"24","author":"Anderson","year":"2004","journal-title":"J Neurosci"},{"key":"R181-3-20210130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1531-8249(200002)47:2<186::AID-ANA8>3.0.CO;2-3","article-title":"Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine","volume":"47","author":"Nath","year":"2000","journal-title":"Ann Neurol"},{"key":"R182-3-20210130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1310\/hct1101-59","article-title":"Memantine for AIDS dementia complex: open-label report of ACTG 301","volume":"11","author":"Zhao","year":"2010","journal-title":"HIV Clin Trials"},{"key":"R183-3-20210130","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/QAD.0b013e32813384e8","article-title":"Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study","volume":"21","author":"Schifitto","year":"2007","journal-title":"AIDS"},{"key":"R184-3-20210130","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.293.16.2003","article-title":"Neuroprotective and antihuman immunodeficiency virus activity of minocycline","volume":"293","author":"Zink","year":"2005","journal-title":"JAMA"},{"key":"R185-3-20210130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/13550280490499533","article-title":"A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia","volume":"10","author":"Si","year":"2004","journal-title":"J Neurovirol"},{"key":"R186-3-20210130","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1471-4159.2005.03219.x","article-title":"Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity","volume":"94","author":"Kraus","year":"2005","journal-title":"J Neurochem"},{"key":"R187-3-20210130","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1086\/651277","article-title":"Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells","volume":"201","author":"Szeto","year":"2010","journal-title":"J Infect Dis"},{"key":"R188-3-20210130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/mcne.2002.1196","article-title":"Lithium ameliorates HIV-gp120-mediated neurotoxicity","volume":"21","author":"Everall","year":"2002","journal-title":"Mol Cell Neurosci"},{"key":"R189-3-20210130","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1097\/01.aids.0000244208.49123.1b","article-title":"Lithium improves HIV-associated neurocognitive impairment","volume":"20","author":"Letendre","year":"2006","journal-title":"AIDS"},{"key":"R190-3-20210130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/13550280902758973","article-title":"Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment","volume":"15","author":"Schifitto","year":"2009","journal-title":"J Neurovirol"},{"key":"R191-3-20210130","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000034177.47015.DA","article-title":"A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment","volume":"59","author":"Clifford","year":"2002","journal-title":"Neurology"},{"key":"R192-3-20210130","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/00002030-199813000-00013","article-title":"Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects","volume":"12","author":"Allard","year":"1998","journal-title":"AIDS"},{"key":"R193-3-20210130","first-page":"72","article-title":"Green Tea-EGCG reduces GFAP associated neuronal loss in HIV-1 Tat transgenic mice","volume":"1","author":"Rrapo","year":"2009","journal-title":"Am J Transl Res"},{"key":"R194-3-20210130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaci.2008.12.024","article-title":"Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy","volume":"123","author":"Nance","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R195-3-20210130","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2006.09.057","article-title":"EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK\/STAT1 signaling and implications for HIV-associated dementia.","volume":"1123","author":"Giunta","year":"2006","journal-title":"Brain Res"},{"key":"R196-3-20210130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.49.1.142","article-title":"Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders.","volume":"49","year":"1997","journal-title":"Neurology"},{"key":"R197-3-20210130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11481-006-9054-y","article-title":"The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system","volume":"2","author":"Letendre","year":"2007","journal-title":"J Neuroimmune Pharmacol"},{"key":"R198-3-20210130","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.addr.2009.11.020","article-title":"Nanotechnology applications for improved delivery of antiretroviral drugs to the brain","volume":"62","author":"Wong","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"R199-3-20210130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2174\/157016210791330356","article-title":"Enhancing the delivery of anti retroviral drug \u2018Saquinavir\u2019 across the blood brain barrier using nanoparticles","volume":"8","author":"Mahajan","year":"2010","journal-title":"Curr HIV Res"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e3283437f9a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:52:19Z","timestamp":1786042339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201103130-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,13]]},"references-count":192,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283437f9a","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,13]]}}}